|
LASS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.523600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.185360E-01 |
| Normal-vs-Stage2 |
2.705800E-02 |
| Normal-vs-Stage3 |
1.099760E-02 |
| Normal-vs-Stage4 |
9.956500E-03 |
| Stage1-vs-Stage2 |
1.313380E-01 |
| Stage1-vs-Stage3 |
4.933900E-02 |
| Stage1-vs-Stage4 |
2.193200E-01 |
| Stage2-vs-Stage3 |
4.503600E-01 |
| Stage2-vs-Stage4 |
9.474200E-01 |
| Stage3-vs-Stage4 |
4.627600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.588170E-02 |
| Normal-vs-AfricanAmerican |
2.877800E-02 |
| Normal-vs-Asian |
5.290000E-01 |
| Caucasian-vs-AfricanAmerican |
7.622800E-01 |
| Caucasian-vs-Asian |
7.522800E-01 |
| AfricanAmerican-vs-Asian |
7.868200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.046140E-02 |
| Normal-vs-Female |
5.450400E-02 |
| Male-vs-Female |
8.978800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.472300E-02 |
| Normal-vs-Extreme_Weight |
1.729560E-01 |
| Normal-vs-Obese |
3.866200E-02 |
| Normal-vs-Extreme_Obese |
2.146400E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.702800E-01 |
| Normal_Weight-vs-Obese |
7.217600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.730200E-01 |
| Extreme_Weight-vs-Obese |
3.906200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.285000E-01 |
| Obese-vs-Extreme_Obese |
4.610400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.053700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.384400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.327200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.123600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.310200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.182600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.589200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.416500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.365200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.010200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.141200E-03 |
| Normal-VS-Type2 PRCC |
6.517700E-03 |
| Normal-VS-KIRP CIMP |
7.780200E-01 |
| Normal-VS-Unclassified PRCC |
2.574400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.503200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.453800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.728200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.529550E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.502400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.878400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.226000E-02 |
| Normal-vs-N1 |
6.803900E-02 |
| Normal-vs-N2 |
1.496820E-01 |
| N0-vs-N1 |
6.878600E-01 |
| N0-vs-N2 |
9.416600E-01 |
| N1-vs-N2 |
9.017800E-01 |
|
|
